SUPT4H1 and Huntington disease: Other studies have also demonstrated that silencing the murine homolog Supt4h in mouse models of Huntington’s disease led to reduced expression of mutant huntingtin mRNA, decreased formation of polyQ aggregates, and improvement in disease-related phenotypes [32].